BUZZ-10x Genomics rises on collaboration to build patient tissue database

Reuters03-25 22:49

BUZZ-<a href="https://laohu8.com/S/TXG">10x Genomics</a> rises on collaboration to build patient tissue database

** Shares of life sciences tech firm 10x Genomics TXG.O rise 3.58% to $20.52

** Privately-held biotech AI firm Bioptimus launches STELA, a global project to build a large database of patient tissue samples linked to clinical records, starting with cancer and immunology

** TXG will provide its Xenium platform to STELA for mapping gene activity in tissue samples, while another partner, Broad Clinical Labs, will help generate the data at scale under a multi-year agreement

** Bioptimus says the project will combine tissue images, spatial gene data, other molecular data and long-term patient records

** The companies did not disclose the financial terms of the deal

** TXG rose more than 13% in 2025

(Reporting by Kunal Das in Bengaluru)

((Kunal.Das2@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622775320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-25 22:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622775320","market":"nz","top_or_hot":-1,"title":"BUZZ-10x Genomics rises on collaboration to build patient tissue database","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/TXG\">10x Genomics</a> rises on collaboration to build patient tissue database</title></head><body><p>** Shares of life sciences tech firm 10x Genomics <span>TXG.O</span> rise 3.58% to $20.52 </p><p>** Privately-held biotech AI firm Bioptimus <span>launches</span> STELA, a global project to build a large database of patient tissue samples linked to clinical records, starting with cancer and immunology</p><p>** TXG will provide its Xenium platform <span>to STELA </span>for mapping gene activity in tissue samples, while another partner, Broad Clinical Labs, will help generate the data at scale under a multi-year agreement</p><p>** Bioptimus says the project will combine tissue images, spatial gene data, other molecular data and long-term patient records</p><p>** The companies did not disclose the financial terms of the deal</p><p>** TXG rose more than 13% in 2025 </p><p>(Reporting by Kunal Das in Bengaluru)</p><p>((Kunal.Das2@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-10x Genomics rises on collaboration to build patient tissue database</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-10x Genomics rises on collaboration to build patient tissue database\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-25 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/TXG\">10x Genomics</a> rises on collaboration to build patient tissue database</title></head><body><p>** Shares of life sciences tech firm 10x Genomics <span>TXG.O</span> rise 3.58% to $20.52 </p><p>** Privately-held biotech AI firm Bioptimus <span>launches</span> STELA, a global project to build a large database of patient tissue samples linked to clinical records, starting with cancer and immunology</p><p>** TXG will provide its Xenium platform <span>to STELA </span>for mapping gene activity in tissue samples, while another partner, Broad Clinical Labs, will help generate the data at scale under a multi-year agreement</p><p>** Bioptimus says the project will combine tissue images, spatial gene data, other molecular data and long-term patient records</p><p>** The companies did not disclose the financial terms of the deal</p><p>** TXG rose more than 13% in 2025 </p><p>(Reporting by Kunal Das in Bengaluru)</p><p>((Kunal.Das2@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL4N40D0UH:1","article_id":"2622775320","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622775320","pubTimestamp":1774450182,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-10x Genomics rises on collaboration to build patient tissue database** Shares of life sciences tech firm 10x Genomics TXG.O rise 3.58% to $20.52 ** Privately-held biotech AI firm Bioptimus launches STELA, a global project to build a large database of patient tissue samples linked to clinical records, starting with cancer and immunology** TXG will provide its Xenium platform to STELA for mapping gene activity in tissue samples, while another partner, Broad Clinical Labs, will help generate the data at scale under a multi-year agreement** Bioptimus says the project will combine tissue images, spatial gene data, other molecular data and long-term patient records** The companies did not disclose the financial terms of the deal** TXG rose more than 13% in 2025 ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4121":"生命科学工具和服务","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","TXG":"10x Genomics, Inc.","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓"},"translate_title":"BUZZ-10x Genomics因合作建立患者组织数据库而崛起","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":0.9},"content_text":"BUZZ-10x Genomics rises on collaboration to build patient tissue database** Shares of life sciences tech firm 10x Genomics TXG.O rise 3.58% to $20.52 ** Privately-held biotech AI firm Bioptimus launches STELA, a global project to build a large database of patient tissue samples linked to clinical records, starting with cancer and immunology** TXG will provide its Xenium platform to STELA for mapping gene activity in tissue samples, while another partner, Broad Clinical Labs, will help generate the data at scale under a multi-year agreement** Bioptimus says the project will combine tissue images, spatial gene data, other molecular data and long-term patient records** The companies did not disclose the financial terms of the deal** TXG rose more than 13% in 2025 (Reporting by Kunal Das in Bengaluru)((Kunal.Das2@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622775320","isCrawlerRequest":true}